4
Changes in Ownership
Pyxis Oncology, Inc. Filed Acc 0000950170-25-048892
Options or other derivatives
- Director acquired 36,979 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| FLAVIN JOHN L Director | 2025-03-31 | Grant or award · Stock Option (Right to Buy) | +36,979 | $0.98 | $36,239 | 36,979 | D |
Loading xslF345X05/ownership.xml…